Demand for Unapproved Weight-Loss Drug Surges on Social Media

(MedPage Today) — The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers.
Five U.S. firms and one in Germany received similarly worded…